Suchen
Faeth Therapeutics Ord Shs
FTHZur Watchlist hinzufügen
27.250USD
+0.010+0.04%
Handelsschluss 07-31 16:00（ET）Kurse um 15 Minuten verzögert
36.52MMarktkapitalisierung
--KGV TTM
mehr Informationen über Unternehmen
Faeth Therapeutics Ord Shs Informationen
Börsenkürzel- -
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
Wertpapierart- -
Geschäftsjahresende- -
Addresse- -
Stadt- -
Börse- -
Land- -
Postleitzahl- -
Telefon- -
Website- -
Börsenkürzel- -
IPO-datum- -
CEO- -
Führungskräfte von Faeth Therapeutics Ord Shs
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Bob Holmen
Mr. Bob Holmen
Independent Director
Independent Director
1.28K
-0.08%
Mr. Josiah Craver
Mr. Josiah Craver
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
--
--
Mr. Christopher W. Gerry
Mr. Christopher W. Gerry
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Phillip B. Donenberg
Mr. Phillip B. Donenberg
Independent Director
Independent Director
--
--
Mr. Anand K. Parikh, J.D.
Mr. Anand K. Parikh, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Stephen M. Hahn, M.D.
Mr. Stephen M. Hahn, M.D.
Director
Director
--
--
Ms. Saira Ramasastry
Ms. Saira Ramasastry
Director
Director
--
--
Ms. Karen Vousden
Ms. Karen Vousden
Director
Director
--
--
Mr. Brian Stephenson, Ph.D.
Mr. Brian Stephenson, Ph.D.
Chief Financial Officer and Principal Financial Officer
Chief Financial Officer and Principal Financial Officer
--
--
Mr. Oliver Maddocks, Ph.D.
Mr. Oliver Maddocks, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Bob Holmen
Mr. Bob Holmen
Independent Director
Independent Director
1.28K
-0.08%
Mr. Josiah Craver
Mr. Josiah Craver
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
--
--
Mr. Christopher W. Gerry
Mr. Christopher W. Gerry
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Phillip B. Donenberg
Mr. Phillip B. Donenberg
Independent Director
Independent Director
--
--
Mr. Anand K. Parikh, J.D.
Mr. Anand K. Parikh, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Stephen M. Hahn, M.D.
Mr. Stephen M. Hahn, M.D.
Director
Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Faeth Therapeutics Ord Shs?
Die fünf größten Anteilseigner von Faeth Therapeutics Ord Shs sind: Mr. Bob Holmen